Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Orchard Therapeutics has raised $34.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2023.
Orchard Therapeutics's investors include Temasek, RA Capital Management, Perceptive Advisors, Foresite Capital, Cormorant Asset Management.
Orchard Therapeutics is headquartered in London, United Kingdom.
Orchard Therapeutics is a biotechnology company dedicated to assisting patients through innovative gene therapies.
Orchard Therapeutics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Orchard Therapeutics — Funding & Investors." VCBacked, March 6, 2023, https://www.vcbacked.co/company/orchard-therapeutics. Accessed September 29, 2026.
VCBacked. (2023). Orchard Therapeutics — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/orchard-therapeutics
{{cite web |title=Orchard Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/orchard-therapeutics |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated